These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16632354)

  • 1. A new class of selective, non-basic 5-HT2A receptor antagonists.
    Ladduwahetty T; Boase AL; Mitchinson A; Quin C; Patel S; Chapman K; MacLeod AM
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3201-4. PubMed ID: 16632354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Fluorosulfonylpiperidines: selective 5-HT2A ligands for the treatment of insomnia.
    Fish LR; Gilligan MT; Humphries AC; Ivarsson M; Ladduwahetty T; Merchant KJ; O'Connor D; Patel S; Philipps E; Vargas HM; Hutson PH; MacLeod AM
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3665-9. PubMed ID: 15993598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists.
    Goodacre CJ; Bromidge SM; Clapham D; King FD; Lovell PJ; Allen M; Campbell LP; Holland V; Riley GJ; Starr KR; Trail BK; Wood MD
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4989-93. PubMed ID: 16168649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P; Subra G; Verdie P; Gabzdyl E; Bojarski AJ; Duszyńska B; Martinez J; Pawłowski M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4827-31. PubMed ID: 19560916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders.
    Ladduwahetty T; Gilligan M; Humphries A; Merchant KJ; Fish R; McAlister G; Ivarsson M; Dominguez M; O'Connor D; MacLeod AM
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3708-12. PubMed ID: 20493697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.
    Heinrich T; Böttcher H; Prücher H; Gottschlich R; Ackermann KA; van Amsterdam C
    ChemMedChem; 2006 Feb; 1(2):245-55. PubMed ID: 16892357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of novel fused thiophene derivatives as 5-HT2A receptor antagonists: molecular modeling study.
    El-Kerdawy MM; El-Bendary ER; Abdel-Aziz AA; El-wasseef DR; El-Aziz NI
    Eur J Med Chem; 2010 May; 45(5):1805-20. PubMed ID: 20149493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
    Chang-Fong J; Tyacke RJ; Lau A; Westaway J; Hudson AL; Glennon RA
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1003-5. PubMed ID: 15013010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
    Obniska J; Pawłowski M; Kołaczkowski M; Czopek A; Duszyńska B; Klodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F; Król M; Kleps J; Nowak G
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors.
    Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1565-9. PubMed ID: 17254782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors.
    Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1570-4. PubMed ID: 17251022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and optimisation of 5-amino-7-aryldihydro-1,4-diazepines as 5-HT2A ligands.
    Swain CJ; Teran A; Maroto M; Cabello A
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6058-62. PubMed ID: 16971119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
    Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.
    Arora J; Bordeleau M; Dube L; Jarvie K; Mazzocco L; Peragine J; Tehim A; Egle I
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5253-6. PubMed ID: 16168646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes.
    Orlandini E; Rapposelli S; Nencetti S; Giannaccini G; Betti L; Balsamo A
    Arch Pharm (Weinheim); 2007 Mar; 340(3):135-9. PubMed ID: 17335104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
    Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
    J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.